MarketInOut Stock Screener Log In | Sign Up

Botanix Pharmaceuticals Ltd

Healthcare • Biotechnology • Quote as of 10/28/2026 16:16
Botanix Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization33.14 mln
Float2,403 mln
Earnings Date03/03/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

3.57
Highly suspicious

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.41
Low leverage

Pre-Tax Margin

-202%
Severely loss-making

ROE

-105
Deeply negative

Business Description

Botanix Pharmaceuticals is an Australian-American company focused on developing and selling prescription skin treatments. Its main product, Sofdra, is a topical gel that reduces excessive underarm sweating in adults and children aged 9 and older. The company is also working on a range of additional treatments targeting acne, rosacea, a resistant bacterial skin infection, and eczema. Founded in 1984 and headquartered in West Perth, Australia, Botanix continues to grow its presence in the dermatology market.

Key Fundamentals

EPS-0.03
ROE-105
RPS0.02
ROIC-124
ROA-62.73
Interest Cover-24.43
EBITDA, mln-64.61
EV / EBITDA-0.50
EV / EBIT-0.48
Revenue, mln34.51
EV / Revenue0.93

Quote Details

Last 0.011
Change 0 (0%)
Open 0.011
Volume 21,228,656
Turnover 233,515
Average Volume 10,167,935

Financial Ratios

Pre-Tax Profit Margin-202
Leverage Ratio1.67
Current Ratio2.59
Price / Book0.78
Price / Tangible Book1.80
Debt / Equity0.41
Price / Sales1.13

Financial Strength

Altman Z-Score-3.76
Piotroski F-Score 5 / 9
Beneish M-Score3.57

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -15.38% 4 / 100   
1 Month -38.89% 2 / 100   
2 Months -52.17% 2 / 100   
6 Months -57.69% 6 / 100   
1 Year -91.54% 0 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog